150 related articles for article (PubMed ID: 6825366)
21. Prospective management of a child with neonatal citrullinemia.
Melnyk AR; Matalon R; Henry BW; Zeller WP; Lange C
J Pediatr; 1993 Jan; 122(1):96-8. PubMed ID: 8419623
[TBL] [Abstract][Full Text] [Related]
22. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.
Ratnakumari L; Qureshi IA; Butterworth RF
Metabolism; 1993 Aug; 42(8):1039-46. PubMed ID: 8102193
[TBL] [Abstract][Full Text] [Related]
23. Severe ornithine transcarbamylase deficiency. Two and a half years' survival with normal development.
Guibaud P; Baxter P; Bourgeois J; Louis JJ; Bureau J
Arch Dis Child; 1984 May; 59(5):477-9. PubMed ID: 6428329
[TBL] [Abstract][Full Text] [Related]
24. Treatment of urea cycle disorders.
Thoene JG
J Pediatr; 1999 Mar; 134(3):255-6. PubMed ID: 10064655
[No Abstract] [Full Text] [Related]
25. [Living related liver transplantation for patients with ornithine transcarbamylase deficiency].
Tazuke M; Murakawa M; Nakao S; Mukaida K; Toda H; Mori K
Masui; 1997 Jun; 46(6):783-7. PubMed ID: 9223881
[TBL] [Abstract][Full Text] [Related]
26. [Abrupt onset and rapid deterioration in the course of congenital ornithine transcarbamylase deficiency: a case report].
Fukuizumi H; Kudo J; Shimamura R; Fujimoto K; Ishibashi H; Niho Y; Taniyama T; Kumashiro T
Fukuoka Igaku Zasshi; 1990 Jul; 81(7):247-53. PubMed ID: 2210591
[TBL] [Abstract][Full Text] [Related]
27. Effect of alternative pathway therapy on branched chain amino acid metabolism in urea cycle disorder patients.
Scaglia F; Carter S; O'Brien WE; Lee B
Mol Genet Metab; 2004 Apr; 81 Suppl 1():S79-85. PubMed ID: 15050979
[TBL] [Abstract][Full Text] [Related]
28. Hyperargininemia: clinical course and treatment with sodium benzoate and phenylacetic acid.
Mizutani N; Maehara M; Hayakawa C; Kato T; Watanabe K; Suzuki S
Brain Dev; 1983; 5(6):555-63. PubMed ID: 6670711
[TBL] [Abstract][Full Text] [Related]
29. Attempted dietary treatment of a boy with hyperammonemia due to ornithine transferase deficiency.
van der Heiden C; Bakker HD; Desplanque J; Brink M; de Bree PK; Wadman SK
Eur J Pediatr; 1978 Jul; 128(4):261-72. PubMed ID: 668733
[TBL] [Abstract][Full Text] [Related]
30. Treatment of urea cycle disorders.
Batshaw ML; Monahan PS
Enzyme; 1987; 38(1-4):242-50. PubMed ID: 3326732
[TBL] [Abstract][Full Text] [Related]
31. [Profile of hepatic and muscular acylcarnitines in chronically hyperammonemic mice after an acute treatment with sodium benzoate: dose-response study].
Michalak A; Qureshi IA
Ann Biol Clin (Paris); 1993; 51(10-11):879-85. PubMed ID: 8210064
[TBL] [Abstract][Full Text] [Related]
32. Benzoate therapy and carnitine deficiency in non-ketotic hyperglycinemia.
Van Hove JL; Kishnani P; Muenzer J; Wenstrup RJ; Summar ML; Brummond MR; Lachiewicz AM; Millington DS; Kahler SG
Am J Med Genet; 1995 Dec; 59(4):444-53. PubMed ID: 8585564
[TBL] [Abstract][Full Text] [Related]
33. Treatment of hyperargininemia with sodium benzoate and arginine-restricted diet.
Qureshi IA; Letarte J; Ouellet R; Batshaw ML; Brusilow S
J Pediatr; 1984 Mar; 104(3):473-6. PubMed ID: 6707802
[No Abstract] [Full Text] [Related]
34. Magnetic resonance spectroscopy shows increased brain glutamine in ornithine carbamoyl transferase deficiency.
Connelly A; Cross JH; Gadian DG; Hunter JV; Kirkham FJ; Leonard JV
Pediatr Res; 1993 Jan; 33(1):77-81. PubMed ID: 8433866
[TBL] [Abstract][Full Text] [Related]
35. [Partial ornithine carbamyl transferase deficiency].
Largillière C
Pediatrie; 1988; 43(4):309-12. PubMed ID: 3419873
[TBL] [Abstract][Full Text] [Related]
36. Free and esterified coenzyme A in the liver and muscles of chronically hyperammonemic mice treated with sodium benzoate.
Michalak A; Qureshi IA
Biochem Mol Med; 1995 Apr; 54(2):96-104. PubMed ID: 8581365
[TBL] [Abstract][Full Text] [Related]
37. The effectiveness of benzoate in the management of seizures in nonketotic hyperglycinemia.
Wolff JA; Kulovich S; Yu AL; Qiao CN; Nyhan WL
Am J Dis Child; 1986 Jun; 140(6):596-602. PubMed ID: 3706242
[TBL] [Abstract][Full Text] [Related]
38. Hyperammonemic encephalopathy after chemotherapy. Survival after treatment with sodium benzoate and sodium phenylacetate.
del Rosario M; Werlin SL; Lauer SJ
J Clin Gastroenterol; 1997 Dec; 25(4):682-4. PubMed ID: 9451687
[TBL] [Abstract][Full Text] [Related]
39. Partial pyruvate decarboxylase deficiency with profound lactic acidosis and hyperammonemia: responses to dichloroacetate and benzoate.
McCormick K; Viscardi RM; Robinson B; Heininger J
Am J Med Genet; 1985 Oct; 22(2):291-9. PubMed ID: 4050860
[TBL] [Abstract][Full Text] [Related]
40. Chronic sodium benzoate therapy in children with inborn errors of urea synthesis: effect on carnitine metabolism and ammonia nitrogen removal.
Feoli-Fonseca JC; Lambert M; Mitchell G; Melançon SB; Dallaire L; Millington DS; Qureshi IA
Biochem Mol Med; 1996 Feb; 57(1):31-6. PubMed ID: 8812724
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
